CN1269243A - Deactivated clostridium perfringens disease vaccine for ox and its preparation - Google Patents
Deactivated clostridium perfringens disease vaccine for ox and its preparation Download PDFInfo
- Publication number
- CN1269243A CN1269243A CN 99101943 CN99101943A CN1269243A CN 1269243 A CN1269243 A CN 1269243A CN 99101943 CN99101943 CN 99101943 CN 99101943 A CN99101943 A CN 99101943A CN 1269243 A CN1269243 A CN 1269243A
- Authority
- CN
- China
- Prior art keywords
- type
- vaccine
- perfringens
- bacillus perfringens
- bacillus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention relates to a bovine aerogenic capsular clostridial disease inactivated vaccine, and its preparation process includes the following steps: culturing aerogenic capsular clostridium A type with trypsinase-digested soup, culturing aerogenic capsule clostridium C type and D type according to conventional culture process, salting out bactrial liquor by using ammonium sulfate to obtain anatoxin, then dissolving the anatoxin by using colloidal aluminium hydroxide, sterilizing and mildewproofing treatment so as to obtain the invented vaccine which can be used for preventing various bacteria resulting in bovine sudden death effectively.
Description
The present invention relates to a kind of inactivated vaccine of preventing and treating the bacillus perfringens disease, especially a kind of deactivated clostridium perfringens disease vaccine for ox and preparation technology thereof.
Bacillus perfringens (clostridieum welchii) is one of humans and animals important pathogenic bacteria.According to producing ectotoxic difference, this bacterium is divided into 6 bacterial types.Except that the people, bacillus perfringens mainly causes following animal epidemic: A type bacterium easily causes cattle, sheep, rabbit enterotoxemia; The Type B bacterium easily causes lamb dysentery; C type bacterium easily causes cattle, Intestinum Sus domestica toxemia, sheep struck; D type bacterium easily causes sheep, goat, calf enterotoxemia; E type bacterium easily causes sheep lamb, calf enterotoxemia.Be prevention animal bacillus perfringens disease, China have the inactivated vaccine production and supply, wherein has sheep braxy, struck, lamb dysentery, enterotoxemia to unite bacterium; The piglet red dysentery inactivated vaccine; Rabbit bacillus perfringens (A type) inactivated vaccine; The multi-joint dry powder Seedling of clostridial disease etc.Each joins bacterium and lacks the data that are used for cattle, lacks A type bacterial strain in constituting jointly.
In recent years, bacillus perfringens causes that the cattle obituary of only falling ill day by day increases, show according to data such as her Tong County of the bright city in Daxian county, Sichuan Province, Anhui Province, Tanghe County, Henan Province, Jilin Province and Lanzhou veterinary institute of the Chinese Academy of Agricultural Sciences, stable counties, Hainan Province, China recent years cattle " sudden death disease " is to be caused separately or caused with the pasteurellosis bacillus co-infection by A, C, D type bacillus perfringens.Be control cattle sudden death disease, generally join Seedling with A type bacillus perfringens or with the pasteurellosis bacillus manufacturing, do not concentrate, every cattle consumption reaches 8ml, and its shortcoming is to use inconvenience, and the disease that only single A type is caused is effective, and the disease that C, D type are caused is then invalid.
It is to make the various bacterium that the connection Seedling prevents to cause the cattle sudden death for three bacillus perfringens that provide a kind of utilization to cause cattle morbidity that order of the present invention has, the deactivated clostridium perfringens disease vaccine for ox that its epidemic prevention is effective, can effectively prevent the generation of cattle sudden death disease.
Thereby another object of the present invention for provide a kind of utilize unique culture medium culturing A type clostridium toxin tire height and adopt concentration technology after join the preparation technology of Seedling, deactivated clostridium perfringens disease vaccine for ox that few, the easy to use, safe property of consumption is good.
Purpose of the present invention can realize by following measure:
The sick deactivation epidemic disease of a kind of gas for ox capsular clostridium enzyme be bacillus perfringens A type, C type, D type bacterium liquid that weight percentage is respectively 30-50%, 20-40%, 20-40% are mixed/use ammonium sulfate precipitation respectively, the 0.1-0.3 aluminium hydroxide gel saline doubly of bacillus perfringens A, the C of the toxoid of getting float after saltouing and be bacillus perfringens A, C, D type when not extracting, the long-pending total amount of D type bacteria liquid dissolves and obtains vaccine.Wherein sick A, C of bacillus perfringens, D type strain are from China Veterinary Drugs Supervisory Inst., and its title code name is respectively C57-1, C59-2, C60-2.
Another object of the present invention also can realize by following measure:
A kind of preparation technology of deactivated clostridium perfringens disease vaccine for ox comprises the steps: 1. bacillus perfringens A type to be cultivated 5-12 hour results bacterium liquid with trypsinization soup; Bacillus perfringens C, D type are cultivated results bacterium liquid with meat liver gastric enzyme digestion soup; 2. Shou Huo bacillus perfringens A, C, D type mix/are used ammonium sulfate precipitation respectively by weight percentage 30-50%, 20-40%, 20-40% separately, and the weight ratio of its mixing/minute other bacterium liquid and ammonium sulfate is 100: (45-75); 3. the float after will saltouing is that the 0.1-0.3 aluminium hydroxide gel saline doubly of bacillus perfringens A, C when not extracting of the toxoid of bacillus perfringens A, C, D type, the long-pending total amount of D type bacteria liquid dissolves and obtains vaccine; 4. add formalin by the 0.1-0.3% that dissolves the back total amount again; 5. and then vaccine is done mildew-resistant handle and to get final product.
The present invention has following advantage compared to existing technology:
1, the present invention will cause that bacillus perfringens A, C, the D type of cattle sudden death are united and join Seedling, thereby the defective that the effect that has overcome single Seedling is single, brought into play various bacterium to causing the synergy of the various disease that cattle dies suddenly, epidemic prevention of the present invention is effective, can effectively prevent the generation of cattle sudden death disease through evidence.
2, adopt improved trypsinization soup to cultivate to A type bacillus perfringens among the preparation technology of the present invention, the clostridial virulence of A type that this culture medium culturing goes out is compared the high 5-10 of virulence times that meat liver gastric enzyme digestion soup is cultivated, thereby the vaccine quality of turning out is good.
3, the present invention joins bacterium, its consumption few (every cattle is only used 2 milliliters) thereby easy to use, safe after vaccine is concentrated.
The present invention also will be described in further detail in conjunction with the embodiments:
Embodiment one:
A kind of deactivated clostridium perfringens disease vaccine for ox is weight percentage to be respectively 36%, 32%, 32% bacillus perfringens A type, C type, D type bacterium liquid mix the back ammonium sulfate precipitation, the weight ratio of bacillus perfringens A, C, D type mixed bacteria liquid and ammonium sulfate is 100: 50, and bacillus perfringens A, the C of the toxoid of getting float after saltouing and be bacillus perfringens A, C, D type when not extracting, the long-pending total amount of D type bacteria liquid 0.2 times 18% aluminium hydroxide gel saline dissolves and obtains vaccine; And then carry out aseptic process and get final product.
A kind of preparation technology of deactivated clostridium perfringens disease vaccine for ox comprises the steps: 1. bacillus perfringens A type to be cultivated 10 hours by the multi-joint dry powder seedling-growing method results of clostridial disease bacterium liquid with trypsinization soup; To press the multi-joint dry powder seedling-growing method preparation of clostridial disease results bacterium liquid behind bacillus perfringens C, the D type usefulness meat liver gastric enzyme digestion soup culture medium culturing; 2. Shou Huo bacillus perfringens A, C, D type connect separately weight percentage 36%, 32%, 32% and mix and use ammonium sulfate precipitation, and the weight ratio of its mixed bacteria liquid and ammonium sulfate is 100: 50; 3. the float after will saltouing is that bacillus perfringens A, C when not extracting of the toxoid of bacillus perfringens A, C, D type, the long-pending total amount of D type bacteria liquid 0.2 times 18% aluminium hydroxide gel saline dissolves and obtains vaccine; 4. again by the 0.2% adding formalin of dissolving the back total amount; 5. handle and then with 37 ℃ of 1,/20,000 thimerosal that vaccine adds total amount and to get final product in 24-48 hour.Described trypsinization soup is beef to be boiled into meat soup and peptone water be made into by weight 1: 1, wherein peptone water be the beef slag that will boil with the pancreas Digestive system routinely technology digest and form.
Embodiment two:
A kind of deactivated clostridium perfringens disease vaccine for ox is weight percentage to be respectively 42%, 29%, 29% bacillus perfringens A type, C type, D type bacterium liquid use ammonium sulfate precipitation respectively, bacillus perfringens A, C, D type are 100: 60 with the weight ratio of ammonium sulfate respectively, and the toxoid of getting float after saltouing and be bacillus perfringens A, C, D type mixes bacillus perfringens A, C when not extracting, the long-pending total amount of D type bacteria liquid 0.3 times 20% aluminium hydroxide gel saline and dissolves and obtain vaccine; And then carry out aseptic process and get final product.
Its preparation technology and example together, wherein the weight percentage of bacillus perfringens A, C, D type and with the ratio of the ratio of ammonium sulfate and aluminium hydroxide gel by requirement in the present embodiment.
Embodiment three:
A kind of deactivated clostridium perfringens disease vaccine for ox is weight percentage to be respectively 48%, 26%, 26% bacillus perfringens A type, C type, D type bacterium liquid mix the back ammonium sulfate precipitation, the weight ratio of bacillus perfringens A, C, D type mixed bacteria liquid and ammonium sulfate is 100: 72, and bacillus perfringens A, the C of the toxoid of getting float after saltouing and be bacillus perfringens A, C, D type when not extracting, the long-pending total amount of D type bacteria liquid 0.1 times 25% aluminium hydroxide gel saline dissolves and obtains vaccine; And then carry out aseptic process and get final product.
Its preparation technology and example together, wherein the weight percentage of bacillus perfringens A, C, D type and with the ratio of the ratio of ammonium sulfate and aluminium hydroxide gel by requirement in the present embodiment.
Claims (3)
1, a kind of deactivated clostridium perfringens disease vaccine for ox, it is characterized in that this vaccine be bacillus perfringens A type, C type, D type bacterium liquid that weight percentage is respectively 30-50%, 20-40%, 20-40% are mixed contain/use ammonium sulfate precipitation respectively, the 0.1-0.3 aluminium hydroxide gel saline doubly of bacillus perfringens A, the C of the toxoid of getting float after saltouing and be bacillus perfringens A, C, D type when not extracting, the long-pending total amount of D type bacteria liquid dissolves and obtains vaccine.
2, the preparation technology of the described deactivated clostridium perfringens disease vaccine for ox of a kind of claim 1 is characterized in that comprising the steps: 1. bacillus perfringens A type being cultivated 5-12 hour results bacterium liquid with trypsinization soup; Bacillus perfringens C, D type are cultivated results bacterium liquid with meat liver gastric enzyme digestion soup; 2. Shou Huo bacillus perfringens A, C, D type mix/are used ammonium sulfate precipitation respectively by weight percentage 30-50%, 20-40%, 20-40% separately, and the weight ratio of its mixing/minute other bacterium liquid and ammonium sulfate is 100: (45-75); 3. the float after will saltouing is that the 0.1-0.3 aluminium hydroxide gel doubly of bacillus perfringens A, C when not extracting of the toxoid of bacillus perfringens A, C, D type, the long-pending total amount of D type bacteria liquid dissolves and obtains vaccine; 4. add formalin by the 0.1-0.3% that dissolves the back total amount again; 5. and then vaccine is done mildew-resistant handle and to get final product.
3, the preparation technology of deactivated clostridium perfringens disease vaccine for ox as claimed in claim 2, it is characterized in that described trypsinization soup is beef to be boiled into meat soup and peptone water be made into by weight 1: 1, wherein peptone water be the beef slag that will boil with the pancreas Digestive system routinely technology digest and form.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB991019431A CN1141976C (en) | 1999-04-01 | 1999-04-01 | Deactivated clostridium perfringens disease vaccine for ox and its preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB991019431A CN1141976C (en) | 1999-04-01 | 1999-04-01 | Deactivated clostridium perfringens disease vaccine for ox and its preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1269243A true CN1269243A (en) | 2000-10-11 |
| CN1141976C CN1141976C (en) | 2004-03-17 |
Family
ID=5270682
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB991019431A Expired - Fee Related CN1141976C (en) | 1999-04-01 | 1999-04-01 | Deactivated clostridium perfringens disease vaccine for ox and its preparation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1141976C (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1293918C (en) * | 2003-03-13 | 2007-01-10 | 山东农业大学 | Prepn of clostridium welchil toxoid vaccine and antitoxin serum |
| CN102698259A (en) * | 2012-06-12 | 2012-10-03 | 北京中海生物科技有限公司 | Preparation method for necrotic enteritis (Type A) inactivated vaccine |
| CN103463632A (en) * | 2013-09-05 | 2013-12-25 | 山东农业大学 | Preparation method for D type clostridium perfringen toxoid vaccine of cattle and sheep enterotoxaemia |
| CN103721254A (en) * | 2013-12-31 | 2014-04-16 | 鄂尔多斯市旭和畜牧有限责任公司 | Method for preparing swine A-type clostridium perfringens aluminum hydroxide inactivated vaccine |
| CN106177935A (en) * | 2016-08-19 | 2016-12-07 | 齐鲁动物保健品有限公司 | A kind of ruminant clostridial disease tetrad inactivated vaccine and preparation method thereof |
| WO2020068635A1 (en) | 2018-09-25 | 2020-04-02 | Toyota Motor Engineering & Manufacturing North America, Inc. | Nano-alloy interphase for lithium metal solid state batteries |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102688484B (en) * | 2012-06-13 | 2016-03-30 | 北京中海生物科技有限公司 | A kind of production method of chicken necrotizing enterocolitis (C type) inactivated vaccine |
-
1999
- 1999-04-01 CN CNB991019431A patent/CN1141976C/en not_active Expired - Fee Related
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1293918C (en) * | 2003-03-13 | 2007-01-10 | 山东农业大学 | Prepn of clostridium welchil toxoid vaccine and antitoxin serum |
| CN102698259A (en) * | 2012-06-12 | 2012-10-03 | 北京中海生物科技有限公司 | Preparation method for necrotic enteritis (Type A) inactivated vaccine |
| CN103463632A (en) * | 2013-09-05 | 2013-12-25 | 山东农业大学 | Preparation method for D type clostridium perfringen toxoid vaccine of cattle and sheep enterotoxaemia |
| CN103463632B (en) * | 2013-09-05 | 2016-01-06 | 山东农业大学 | The preparation method of the D type bacillus perfringens toxoid vaccine of cattle and sheep enterotoxemia |
| CN103721254A (en) * | 2013-12-31 | 2014-04-16 | 鄂尔多斯市旭和畜牧有限责任公司 | Method for preparing swine A-type clostridium perfringens aluminum hydroxide inactivated vaccine |
| CN106177935A (en) * | 2016-08-19 | 2016-12-07 | 齐鲁动物保健品有限公司 | A kind of ruminant clostridial disease tetrad inactivated vaccine and preparation method thereof |
| WO2020068635A1 (en) | 2018-09-25 | 2020-04-02 | Toyota Motor Engineering & Manufacturing North America, Inc. | Nano-alloy interphase for lithium metal solid state batteries |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1141976C (en) | 2004-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102583776B (en) | Compound bacteria enzyme preparation for improving cultivation watery environment and preparation method | |
| Mergenhagen et al. | Studies on synergistic infections: I. Experimental infections with anaerobic streptococci | |
| White et al. | Streptococcus SBE: a streptococcus associated with subacute bacterial endocarditis | |
| CN1856569B (en) | Animal product free process for obtaining a botulinum toxin and culture medium | |
| CN101444252B (en) | Method for preparing fermented virus-free cottonseed meal feed protein | |
| CN102703549B (en) | Method for improving percent conversion of tylosin component A | |
| CN1141976C (en) | Deactivated clostridium perfringens disease vaccine for ox and its preparation | |
| CN103602653A (en) | Keratinase with improved thermal stability and specific activity as well as preparation method and application thereof | |
| CN109549025A (en) | One seed shrimp feed addictive and preparation method thereof | |
| CN102174624B (en) | Method for producing enramycin by fermentation | |
| CN103160555A (en) | Culture medium, culture method and application of high-yield exotoxin of clostridium perfringens | |
| CN108721616B (en) | A kind of avian pasteurella multocida capsular polysaccharide-protein conjugate vaccines and preparation method thereof | |
| CN103013947A (en) | Production method of recombinant phospholipase D | |
| CN105002110B (en) | Complex microorganism preparations and its application in the processing of algal bloom water body | |
| KR101229055B1 (en) | Strain of methylobacterium sp. having a alginate-decomposition activity and method of producing alginate-oligomer using the same | |
| CN102732456A (en) | Organic solvent-tolerant glycosidase Fru6, its mutant and its applications | |
| Demain et al. | Effective levels of tetanus toxin can be made in a production medium totally lacking both animal (eg, brain heart infusion) and dairy proteins or digests (eg, casein hydrolysates) | |
| CN102154251A (en) | Method for producing carboxypeptidase by aspergillus niger | |
| CN110452838B (en) | CRM197 strain culture medium, preparation method and fermentation culture method | |
| KR19990025670A (en) | Method for preparing bispan bacteria by liquid fermentation | |
| CN1696282A (en) | Culture medium of anaerobic toxin production in use for producing vaccine of treating disease of sheep clostridium | |
| CN102178052B (en) | Fermented feed additive and preparation method of the fermented feed additive | |
| CN101695568A (en) | A-type clostridium perfringens populus skin lipoid inactivated vaccine and preparation method thereof | |
| CN105950538B (en) | A method of promoting Miyarisan Fermentative growth | |
| CN101182532A (en) | Bifidobacteria-bacillus coli shuttle expression carrier pBES, bifidobacteria-ETEC CFA/I recombinant vector and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |